Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Qingrui Huang

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Nature Communications|February 4, 2021
A single-dose mRNA vaccine provides a long-term protection for hACE2 transgenic mice from SARS-CoV-2Qingrui Huang, Kai Ji, Siyu Tian, et al.
Nature Communications|November 3, 2025
Neutralizing antibodies against Chikungunya virus and structural elucidation of their mechanism of actionXiaonan Han, Chengfan Ji, Siyu Tian, et al.
Nature Communications|August 21, 2025
Highly scalable prefusion-stabilized RSV F vaccine with enhanced immunogenicity and robust protectionQingrui Huang, Qingyun Lang, Yao Li, et al.
Biosafety and Health|May 1, 2023
Rapid evaluation of heterologous chimeric RBD-dimer mRNA vaccine for currently-epidemic Omicron sub-variants as booster shot after inactivated vaccineQian Chen, Pei Du, Yuxuan Han, et al.
Nature Immunology|July 16, 2021
Protective Zika vaccines engineered to eliminate enhancement of dengue infection via immunodominance switchLianpan Dai, Kun Xu, Jinhe Li, et al.
Journal of Virology|January 5, 2018
Recombinant Chimpanzee Adenovirus Vaccine AdC7-M/E Protects against Zika Virus Infection and Testis DamageKun Xu, Yufeng Song, Lianpan Dai, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Nature Communications|February 4, 2021
A single-dose mRNA vaccine provides a long-term protection for hACE2 transgenic mice from SARS-CoV-2Qingrui Huang, Kai Ji, Siyu Tian, et al.
Nature Communications|November 3, 2025
Neutralizing antibodies against Chikungunya virus and structural elucidation of their mechanism of actionXiaonan Han, Chengfan Ji, Siyu Tian, et al.
Nature Communications|August 21, 2025
Highly scalable prefusion-stabilized RSV F vaccine with enhanced immunogenicity and robust protectionQingrui Huang, Qingyun Lang, Yao Li, et al.
Biosafety and Health|May 1, 2023
Rapid evaluation of heterologous chimeric RBD-dimer mRNA vaccine for currently-epidemic Omicron sub-variants as booster shot after inactivated vaccineQian Chen, Pei Du, Yuxuan Han, et al.
Nature Immunology|July 16, 2021
Protective Zika vaccines engineered to eliminate enhancement of dengue infection via immunodominance switchLianpan Dai, Kun Xu, Jinhe Li, et al.
Journal of Virology|January 5, 2018
Recombinant Chimpanzee Adenovirus Vaccine AdC7-M/E Protects against Zika Virus Infection and Testis DamageKun Xu, Yufeng Song, Lianpan Dai, et al.
Pageof 2